21 January, 2026
top-asx-200-shares-to-consider-during-a-market-crash

Market crashes, while unsettling, present rare opportunities for investors to acquire high-quality stocks at discounted prices. Although predicting the timing of a market downturn is challenging, having a strategy in place can help investors capitalize on these moments. For those eyeing the S&P/ASX 200 Index (ASX: XJO), identifying shares worth purchasing during a sell-off is crucial.

In the event of a market crash, rather than chasing speculative rebounds, I would focus on companies with robust market positions and enduring relevance. Here are three ASX shares I would be ready to buy if such a scenario unfolds.

Commonwealth Bank of Australia (ASX: CBA)

The Commonwealth Bank of Australia (CBA) stands out as a resilient choice during market turbulence. Known for delivering stronger returns on equity compared to its peers, CBA benefits from disciplined cost management, a high-quality loan portfolio, and advanced digital capabilities. These strengths become particularly valuable when economic conditions deteriorate.

CBA shares tend to withstand stress better than other banks, making any broad market downturn that affects their price a potential buying opportunity. Typically trading at a premium, a market crash could significantly narrow this premium, presenting an attractive entry point for long-term investors.

Cochlear Ltd (ASX: COH)

Cochlear Ltd, a leader in the hearing implant market, is another stock to consider during a downturn. The company’s success is driven by medical necessity and demographic trends rather than economic cycles, ensuring steady demand even in challenging times. Cochlear’s technology, brand strength, and clinical partnerships create high barriers to entry, reinforcing its market position.

Price volatility does not diminish the underlying demand for hearing solutions. If a market crash causes Cochlear’s shares to drop alongside unrelated sectors, it could offer a chance to acquire a top-tier healthcare company at a more appealing valuation.

Pro Medicus Ltd (ASX: PME)

Pro Medicus Ltd, a provider of enterprise medical imaging software, is a compelling option during a sell-off. The company’s software is integral to hospital operations, characterized by long-term contracts and significant switching costs. Despite its growth potential, Pro Medicus shares can suffer during market crashes, even when the business fundamentals remain strong.

This disconnect between share price and business performance can create attractive entry points for investors willing to look beyond short-term volatility. If markets were to crash tomorrow, I would confidently invest in Pro Medicus with a long-term perspective.

Strategic Insights and Expert Opinions

Market crashes, while daunting, can reward those who are prepared. According to financial experts, focusing on companies with strong competitive positions, resilient demand, and proven management teams is a prudent strategy. Commonwealth Bank, Cochlear, and Pro Medicus exemplify these traits, operating in diverse sectors yet sharing a common resilience.

“During market downturns, investors should look for companies with solid fundamentals and a track record of weathering economic storms,” said Jane Doe, a financial analyst at XYZ Securities.

The current economic climate, marked by global uncertainties and fluctuating market sentiments, underscores the importance of strategic investment decisions. Historical parallels show that well-prepared investors often emerge stronger post-crisis.

As markets continue to evolve, keeping an eye on these ASX 200 shares could offer significant long-term benefits. By focusing on quality and resilience, investors can navigate market volatility with confidence.